Skip to content

Clinical trials

Phase 2 Infant, Newborn, Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Infant, Newborn, Diseases Phase: Phase 2 Country / region: United States Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20092
20141
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated3
Alexion Pharmaceuticals, Inc.1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Kastle Therapeutics, LLC1
National Center for Research Resources (NCRR)1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Infant, Newborn, Diseases8
Genetic Diseases, Inborn5
Cystic Fibrosis3
Lung Diseases3
Pancreatic Diseases3
Digestive System Diseases2
Fibrosis2
Lipid Metabolism Disorders2
Lipid Metabolism, Inborn Errors2
Metabolic Diseases2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.